Correlates of aortic stiffness progression in patients with resistant hypertension: Importance of clinic and ambulatory blood pressure changes

Journal of Hypertension

Volumn 33, Issue 4, 2015, Pages 827-835

  Roderjan, Christian N ^a   Cardoso, Claudia R L ^a   Ferreira, Marcel T ^a   Muxfeldt, Elizabeth S ^a   Salles, Gil F ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Ambulatory blood pressure; Aortic stiffness; Clinic blood pressure; Resistant hypertension; White coat effect

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGED; ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTERY BLOOD FLOW; BLOOD PRESSURE CUFF; BLOOD PRESSURE MONITORING; BLOOD VESSEL FUNCTION; BLOOD VESSEL PARAMETERS; CAROTID ARTERY PULSE; CLINICAL EVALUATION; CONFERENCE PAPER; CORRELATIONAL STUDY; DIABETES MELLITUS; DIURETIC THERAPY; FEMALE; FEMORAL PULSE WAVE VELOCITY; FOLLOW UP; HOSPITAL; HUMAN; INDEPENDENT VARIABLE; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NON INVASIVE BLOOD PRESSURE MONITOR; NORMAL VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESISTANT HYPERTENSION; SENESCENCE; WAIST CIRCUMFERENCE; WHITE COAT HYPERTENSION; DISEASE COURSE; HYPERTENSION; MIDDLE AGED; PATHOPHYSIOLOGY; PULSE WAVE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BLOOD PRESSURE MONITORING, AMBULATORY; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS; WHITE COAT HYPERTENSION;

EID: 84938937190     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000491     Document Type: Conference Paper

References (43)

1. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25:932-943.
2. Laurent S, Boutouyrie P. Recent advances in arterial stiffness and wave reflection in human hypertension. Hypertension 2007; 49:1202-1206.
3. Cavalcante JL, Lima JA, Redheuil A, Al-Mallah MH. Aortic stiffness: current understanding and future directions. J Am Coll Cardiol 2011; 57:1511-1522.
4. Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension 2009; 54:1328-1336.
5. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588-2605.
6. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37:1236-1241.
7. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010; 121:505-511.
8. Cardoso CR, Ferreira MT, Leite NC, Salles GF. Prognostic impact of aortic stiffness in high-risk type 2 diabetic patients: the Rio de Janeiro Type 2 Diabetes Cohort Study. Diabetes Care 2013; 36:3772-3778.
9. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55:1318-1327.
10. Dengo AL, Dennis EA, Orr JS, Marinik EL, Ehrlich E, Davy BM, et al. Arterial destiffening with weight loss in overweight and obese middleaged and older adults. Hypertension 2010; 55:855-861.
11. Fantin F, Rossi A, Morgante S, Soave D, Bissoli L, Cazzadori M, et al. Supervised walking groups to increase physical activity in elderly women with and without hypertension: effect on pulse wave velocity. Hypertens Res 2012; 35:988-993.
12. Boutouyrie P, Beaussier H, Achouba A, Laurent S, EXPLOR trialists. Destiffening effect of valsartan and atenolol: influence of heart rate and blood pressure. J Hypertens 2014; 32:108-114.
13. Aatola H, Hutri-Kahonen N, Juonala M, Viikari JS, Hulkkonen J, Laitinen T, et al. Lifetime risk factors and arterial pulse wave velocity in adulthood: the cardiovascular risk in young Finns study. Hypertension 2010; 55:806-811.
14. McEniery CM, Spratt M, Munnery M, Yarnell J, Lowe GD, Rumley A, et al. An analysis of prospective risk factors for aortic stiffness in men: 20-year follow-up from the Caerphilly prospective study. Hypertension 2010; 56:36-43.
15. Benetos A, Adamopoulos C, Bureau JM, Temmar M, Labat C, Bean K, et al. Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 2002; 105:1202-1207.
16. Wildman RP, Farhat GN, Patel AS, Mackey RH, Brockwell S, Thompson T, et al. Weight change is associated with change in arterial stiffness among healthy young adults. Hypertension 2005; 45:187-192.
17. Ait-Oufella H, Collin C, Bozec E, Laloux B, Ong KT, Dufouil C, et al. Long-term reduction in aortic stiffness: a 5.3-year follow-up in routine clinical practice. J Hypertens 2010; 28:2336-2341.
18. Birru MS, Matthews KA, Thurston RC, Brooks MM, Ibrahim S, Barinas-Mitchell E, et al., SWAN Heart Study. African-American ethnicity and cardiovascular risk factors are related to aortic pulse-wave velocity progression. Am J Hypertens 2011; 24:809-815.
19. El Khoudary SR, Barinas-Mitchell E, White J, Sutton-Tyrrell K, Kuller LH, Curb JD, et al., ERA JUMP Study Group. Adiponectin, systolic blood pressure, and alcohol consumption are associated with more aortic stiffness progression among apparently healthy men. Atherosclerosis 2012; 225:475-480.
20. Kaess BM, Rong J, Larson MG, Hamburg NM, Vita JA, Levy D, et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA 2012; 308:875-881.
21. AlGhatrif M, Strait JB, Morrell CH, Canepa M, Wright J, Elango P, et al. Longitudinal trajectories of arterial stiffness and the role of blood pressure: the Baltimore Longitudinal Study of Aging. Hypertension 2013; 62:934-941.
22. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008; 51:1403-1419.
23. Egan BW, Zhao Y, Axon RN, Brzezinski WA, Ferdinand KC. Uncontrolled and apparent treatment resistant hypertension in the United States, 1998 to 2008. Circulation 2011; 124:1046-1058.
24. Castelpoggi CH, Pereira VS, Fiszman R, Cardoso CR, Muxfeldt ES, Salles GF. A blunted decrease in nocturnal blood pressure is independently associated with increased aortic stiffness in patients with resistant hypertension. Hypertens Res 2009; 32:591-596.
25. Salles G, Cardoso C, Muxfeldt E. Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med 2008; 168:2340-2346.
26. Muxfeldt ES, Bloch KV, Nogueira Ada R, Salles GF. True resistant hypertension: Is it possible to be recognized in the office? Am J Hypertens 2005; 18:1534-1540.
27. Muxfeldt ES, de Souza F, Salles GF. Resistant hypertension: a practical clinical approach. J Hum Hypertens 2013; 27:657-662.
28. Bloch KV, de Melo AN, Nogueira AR. Prevalence of antihypertensive treatment adherence in patients with resistant hypertension and validation of three indirect methods for assessing treatment adherence. Cad Saude Publica 2008; 24:2979-2984.
29. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55:613-618.
30. Jones CR, Taylor K, Chowienczyk P, Poston L, Shennan AH. A validation of the Mobil O Graph (version 12) ambulatory blood pressure monitor. Blood Press Monit 2000; 5:233-238.
31. Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, et al., Artery Society; European Society of Hypertension Working Group on Vascular Structure and Function; European Network for Noninvasive Investigation of Large Arteries. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 2012; 30:445-448.
32. The Reference Values for Arterial Stiffness' Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J 2010; 31:2338-2350.
33. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, et al. Assessment of arterial distensibility by automatic pulse wave velocity: validation and clinical application studies. Hypertension 1995; 26:485-490.
34. Ben-Dov IZ, Kark JD, Mekler J, Shaked E, Bursztyn M. The white coat phenomenon is benign in referred treated patients: a 14-year ambulatory blood pressure mortality study. J Hypertens 2008; 26:699-705.
35. Luzardo L, Lujambio I, Sottolano M, da Rosa A, Thijs L, Noboa O, et al. 24-h ambulatory recording of aortic pulse wave velocity and central systolic augmentation: a feasibility study. Hypertens Res 2012; 35:980-987.
36. Papaioannou TG, Argyris A, Protogerou AD, Vrachatis D, Nasothimiou EG, Sfikakis PP, et al. Noninvasive 24 h ambulatory monitoring of aortic wave reflection and arterial stiffness by a novel oscillometric device: the first feasibility and reproducibility study. Int J Cardiol 2013; 169:57-61.
37. Tomiyama H, Hashimoto H, Hirayama Y, Yambe M, Yamada J, Koji Y, et al. Synergistic acceleration of arterial stiffening in the presence of raised blood pressure and raised plasma glucose. Hypertension 2006; 47:180-188.
38. Tomiyama H, Hashimoto H, Tanaka H, Matsumoto C, Odaira M, Yamada J, et al., baPWV/cfPWV Collaboration Group. Synergistic relationship between changes in the pulse wave velocity and changes in the heart rate in middle-aged Japanese adults: a prospective study. J Hypertens 2010; 28:687-694.
39. Virtanen MP, Koobi T, Turjanmaa VM, Majahalme S, Tuomisto MT, Nieminen T, et al. Predicting arterial stiffness with ambulatory blood pressure: an 11-year follow-up. Clin Physiol Funct Imaging 2008; 28:378-383.
40. Schillaci G, Pucci G, Pirro M, Settimi L, Hijazi R, Franklin SS, et al. Combined effects of office and 24-h blood pressure on aortic stiffness in human hypertension. J Hypertens 2011; 29:869-875.
41. de Simone G, Schillaci G, Chinali M, Angeli F, Reboldi GP, Verdecchia P. Estimate of white-coat effect and arterial stiffness. J Hypertens 2007; 25:827-831.
42. Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol 2005; 34:215-220.
43. Linden A. Assessing regression to the mean effects in healthcare initiatives. BMC Med Res Methodol 2013; 13:119.